0001209191-17-027983.txt : 20170424 0001209191-17-027983.hdr.sgml : 20170424 20170424163416 ACCESSION NUMBER: 0001209191-17-027983 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170424 FILED AS OF DATE: 20170424 DATE AS OF CHANGE: 20170424 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 17778587 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celgene Alpine Investment Co., LLC CENTRAL INDEX KEY: 0001581774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 17778588 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: X1 ZIP: 07901 BUSINESS PHONE: 908-673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: X1 ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celgene Switzerland LLC CENTRAL INDEX KEY: 0001661486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 17778589 BUSINESS ADDRESS: STREET 1: AON HOUSE STREET 2: 30 WOODBOURNE AVENUE CITY: PEMBROKE STATE: D0 ZIP: HM 08 BUSINESS PHONE: 4412964803 MAIL ADDRESS: STREET 1: AON HOUSE STREET 2: 30 WOODBOURNE AVENUE CITY: PEMBROKE STATE: D0 ZIP: HM 08 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celgene European Investment Co LLC CENTRAL INDEX KEY: 0001577650 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 17778590 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: 908-673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-24 0 0001439222 AGIOS PHARMACEUTICALS INC AGIO 0001577650 Celgene European Investment Co LLC 86 MORRIS AVENUE SUMMIT NJ 07901 0 0 1 0 0001661486 Celgene Switzerland LLC AON HOUSE 30 WOODBOURNE AVENUE PEMBROKE D0 HM 08 BERMUDA 0 0 1 0 0001581774 Celgene Alpine Investment Co., LLC 86 MORRIS AVENUE SUMMIT NJ 07901 0 0 1 0 0000816284 CELGENE CORP /DE/ 86 MORRIS AVENUE SUMMIT NJ 07901 0 0 1 0 Common Stock 2017-04-24 4 P 0 624575 49.50 A 1856353 I See footnote Common Stock 4010926 D Of these shares, 624,575 shares are owned directly by Celgene Switzerland LLC ("Celgene Switzerland"), 708,333 shares are owned directly by Celgene Alpine Investment Co. LLC ("Celgene Alpine"), each a wholly-owned subsidiary of Celgene Corporation ("Celgene"), and Celgene has the power to vote, acquire, hold and dispose of all such shares. Celgene and Celgene European Investment Company LLC, a wholly owned subsidiary of Celgene ("CEICO"), disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. The remaining 523,445 shares are owned directly by Celgene. CEICO, Celgene Switzerland and Celgene Alpine disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. These shares are owned directly by CEICO, and Celgene has the power to vote, acquire, hold and dispose of all shares. Celgene, Celgene Switzerland and Celgene Alpine disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. /s/Kevin Mello, Manager, Celgene European Investment Company LLC 2017-04-24 /s/ Kevin Mello, Manager, Celgene Switzerland LLC 2017-04-24 /s/ Kevin Mello, Manager, Celgene Alpine Investment Co., LLC 2017-04-24 /s/ Peter N. Kellogg, Executive Vice President & Chief Financial Officer, Celgene Corporation 2017-04-24